Back
PTC Therapeutics Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
64
PTCT
PTC Therapeutics
Last Price:
31.98
Seasonality Move:
20.4%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
131.82
Seasonality Move:
14.17%
Buy
64
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $32.25. The Score for PTCT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $131.82. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $32.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $131.82
The current trend is moderately bullish and SRPT is experiencing slight buying pressure.
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.26 | Buy |
| Relative Strength Index (14 RSI): | 61.44 | Buy |
| Chaikin Money Flow: | 281278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.4 - 31.9) | Buy |
| Bollinger Bands (100): | (25.94 - 30.42) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.57 | Buy |
| Relative Strength Index (14 RSI): | 59 | Buy |
| Chaikin Money Flow: | 285209 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.48 - 132.12) | Buy |
| Bollinger Bands (100): | (109.28 - 132.8) | Buy |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.5 | Sell |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 29.19 | Buy |
| 200-day SMA: | 28.34 | Buy |
| 8-day EMA: | 31.6 | Buy |
| 20-day EMA: | 30.22 | Buy |
| 50-day EMA: | 28.99 | Buy |
| 200-day EMA: | 30.25 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 132.86 | Sell |
| 20-day SMA: | 125.9 | Buy |
| 50-day SMA: | 125.49 | Buy |
| 200-day SMA: | 112.87 | Buy |
| 8-day EMA: | 131.79 | Buy |
| 20-day EMA: | 128.8 | Buy |
| 50-day EMA: | 125.75 | Buy |
| 200-day EMA: | 117.52 | Buy |
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.47 per share, an increase next quarter of $0.44 per share, a decrease this year of $0.61 per share, and an increase next year of $1.56 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.
PTC Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||